|
Biocoral, Inc., a Delaware corporation, is an international biomaterials
"tissue-engineering" company specializing in the research, development and
commercialization of patented high biotechnologies and biomaterials in the
health care area. Through our subsidiaries, Biocoral, Inc. researches, develops,
manufactures and commercializes bone graft substitutes and other high technology
patented biomaterials in a number of countries outside the United States. We
entered the biomaterials field in 1995 when we acquired Inoteb, SA, a French
corporation from 10 individuals "the founders", all French citizens. The shares
and bonds of Inoteb acquired in 1995 represented, at such time, 51.5% of the
capital stock of Inoteb. We increased our ownership percentage through several
additional investments in Inoteb common stock to 67% in 1997 and to 100% in
1998.
|
|